President Trump has nominated Dr. Nicole Saphier, a radiologist and former Fox News medical contributor who directs breast imaging at Memorial Sloan Kettering Monmouth, to be surgeon general — his third choice for the post often called “the nation’s doctor.” Trump called her a “STAR physician” and an “INCREDIBLE COMMUNICATOR” on Truth Social. His prior picks included Dr. Janette Nesheiwat, who withdrew after scrutiny of how she represented her credentials, and Dr. Casey Means, whose nomination stalled after opposition from key Republican senators.
Saphier is expected to be more acceptable to Republican lawmakers than Means. Trump accused Senate HELP Committee Chair Sen. Bill Cassidy, R-La., of blocking Means’ confirmation and criticized “intransigence and political games.” Senators Susan Collins, R‑Maine, and Lisa Murkowski, R‑Alaska, along with Cassidy, opposed Means, effectively preventing her confirmation. Those same HELP Committee members will question Saphier if a hearing is scheduled; the committee vets health nominees and decides whether to advance them to the full Senate.
Saphier’s mix of clinical credentials and media presence sets her apart from Means. She is an actively licensed physician practicing at a major academic center, has written a book, hosts a podcast, and markets herbal supplement drops. Supporters say those credentials make her a “reasonable choice.” David Mansdoerfer, a former HHS deputy assistant secretary, predicts Saphier will be welcomed by Republicans, noting her stance on pro‑life issues, chronic disease prevention and appeal to suburban voters tied to the Make American Healthy Again (MAHA) movement. Georges Benjamin, CEO of the American Public Health Association, called her a reasonable choice compared with Means, whom he previously described as “less qualified professionally than any other surgeon general in history.”
Former Surgeon General Dr. Jerome Adams said Saphier should earn respect from the medical community, public and administration and called her a “solid pick” likely to be confirmed, though he cautioned she tends to view health through a clinical, diagnosis-and-treatment lens rather than a broader public‑health and societal perspective. Adams noted that public health messaging must account for social determinants — for example, personal responsibility arguments can miss how policy and economic factors shape people’s ability to follow health advice.
A central focus of any confirmation hearing will likely be Saphier’s views on vaccines. The Trump administration has been moving away from a vaccine‑centric message amid political concerns and legal challenges to vaccine policy changes proposed by Health Secretary Robert F. Kennedy Jr. Saphier has criticized Kennedy’s attempts to link vaccines with autism, writing that “we can’t afford to chase ghosts” and calling for more research into genetic and environmental causes of autism. At the same time, she has urged the CDC and American Academy of Pediatrics to be “less stringent” on certain parts of the childhood vaccine schedule, specifically citing hepatitis B and COVID‑19 vaccines for children. Publicly, she has opposed vaccine mandates while not identifying as anti‑vaccine — a stance similar to what stalled Means’ nomination for some senators.
Observers emphasize the broader role of the surgeon general beyond clinical practice. Dr. Richard Carmona, who served as surgeon general under George W. Bush, says the job is to “protect, promote and advance the health, safety and security of the nation,” to lead the U.S. Public Health Service Commissioned Corps, and to represent the U.S. in emergencies and global health discussions. He would prioritize candidates’ leadership and public‑health experience — including work on vaccination policy, environmental health, sanitation, air pollution and emergency preparedness — alongside clinical credentials.
Saphier’s media experience and communication skills could help in the role of public health messaging, but senators and public health leaders will scrutinize whether she brings the population-level experience and perspective that the job requires. Her private-sector activities, such as selling supplements and her media work, may also draw questions about potential conflicts or the appropriateness of a public health official promoting commercial products.
Ultimately, whether Saphier can be confirmed will depend on how she performs at a hearing, how she answers questions about vaccines, public health priorities and her own background, and whether she can secure support from the pivotal Republican senators on the HELP Committee. Some former officials and observers believe she has a reasonable chance of confirmation given her clinical standing and communication skills; others note gaps in public‑health leadership experience that could complicate her path.
